Sign in
4

Changes in Ownership

Tarsus Pharmaceuticals, Inc. Filed Acc 0001788542-26-000007

Chief Commercial Officer sold 13,056 shares at an average $68.36 ($892,528)

From the SEC's structured data for this filing

Trades in this filing

Mottiwala Aziz · Chief Commercial Officer

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2026-03-17 Sale : show line 1 in the form −4,286 $69.42 $297,534 70,250 D
2026-03-18 Sale : show line 2 in the form −4,330 $68.71 $297,514 65,920 D
2026-03-19 Sale : show line 3 in the form −4,440 $67.00 $297,480 61,480 D
Open-market sales · 13,056 sh · avg $68.36 · $892,528
Loading xslF345X06/wk-form4_1773961455.xml…